文化大學機構典藏 CCUR:Item 987654321/48859
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 47225/51091 (92%)
Visitors : 13995462      Online Users : 254
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/48859


    Title: Overall survival prediction of non-small cell lung cancer by integrating microarray and clinical data with deep learning
    Authors: Lai, YH (Lai, Yu-Heng)
    Chen, WN (Chen, Wei-Ning)
    Hsu, TC (Hsu, Te-Cheng)
    Lin, C (Lin, Che)
    Tsao, Y (Tsao, Yu)
    Wu, SM (Wu, Semon)
    Contributors: 化學系
    Keywords: EXPRESSION
    ADENOCARCINOMA
    PROGNOSIS
    CHEMOTHERAPY
    ONCOGENES
    PROTEINS
    GENE
    HUR
    Date: 2020-12-01
    Issue Date: 2020-12-10 13:43:25 (UTC+8)
    Abstract: Non-small cell lung cancer (NSCLC) is one of the most common lung cancers worldwide. Accurate prognostic stratification of NSCLC can become an important clinical reference when designing therapeutic strategies for cancer patients. With this clinical application in mind, we developed a deep neural network (DNN) combining heterogeneous data sources of gene expression and clinical data to accurately predict the overall survival of NSCLC patients. Based on microarray data from a cohort set (614 patients), seven well-known NSCLC biomarkers were used to group patients into biomarker- and biomarker+ subgroups. Then, by using a systems biology approach, prognosis relevance values (PRV) were then calculated to select eight additional novel prognostic gene biomarkers. Finally, the combined 15 biomarkers along with clinical data were then used to develop an integrative DNN via bimodal learning to predict the 5-year survival status of NSCLC patients with tremendously high accuracy (AUC: 0.8163, accuracy: 75.44%). Using the capability of deep learning, we believe that our prediction can be a promising index that helps oncologists and physicians develop personalized therapy and build the foundation of precision medicine in the future.
    Relation: SCIENTIFIC REPORTS 卷冊: 10 期: 1 文獻號碼: 4679
    Appears in Collections:[Department of Chemistry & Graduate Institute of Applied Chemistry ] journal articles

    Files in This Item:

    File Description SizeFormat
    index.html0KbHTML185View/Open


    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback